|
1
|
Williams CD, Stengel J, Asike MI, et al:
Prevalence of nonalcoholic fatty liver disease and nonalcoholic
steatohepatitis among a largely middle-aged population utilizing
ultrasound and liver biopsy: a prospective study. Gastroenterology.
140:124–131. 2011. View Article : Google Scholar
|
|
2
|
Ono M and Saibara T: Clinical features of
nonalcoholic steatohepatitis in Japan: Evidence from the
literature. J Gastroenterol. 41:725–732. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sumida Y, Yoneda M, Hyogo H, et al: A
simple clinical scoring system using ferritin, fasting insulin, and
type IV collagen 7S for predicting steatohepatitis in nonalcoholic
fatty liver disease. J Gastroenterol. 46:257–268. 2011. View Article : Google Scholar
|
|
4
|
Eguchi Y, Hyogo H, Ono M, et al:
Prevalence and associated metabolic factors of nonalcoholic fatty
liver disease in the general population from 2009 to 2010 in Japan:
a multicenter large retrospective study. J Gastroenterol.
47:586–595. 2012. View Article : Google Scholar
|
|
5
|
Nakahara T, Hyogo H, Yoneda M, et al: Type
2 diabetes mellitus is associated with the fibrosis severity in
patients with nonalcoholic fatty liver disease in a large
retrospective cohort of Japanese patients. J Gastroenterol. Nov
26–2013.(Epub ahead of print).
|
|
6
|
Angulo P: Nonalcoholic fatty liver
disease. N Engl J Med. 346:1221–1231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imajo K, Fujita K, Yoneda M, et al:
Hyperresponsivity to low-dose endotoxin during progression to
nonalcoholic steatohepatitis is regulated by leptin-mediated
signaling. Cell Metab. 16:44–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Smith K: Microbiota: Gut microbiota
produce alcohol in patients with NASH. Nat Rev Gastroenterol
Hepatol. 9:6872012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mells JE and Anania FA: The role of
gastrointestinal hormones in hepatic lipid metabolism. Semin Liver
Dis. 33:343–357. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Itou M, Kawaguchi T, Taniguchi E, et al:
Altered expression of glucagon-like peptide-1 and dipeptidyl
peptidase IV in patients with HCV-related glucose intolerance. J
Gastroenterol Hepatol. 23:244–251. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Itou M, Kawaguchi T, Taniguchi E and Sata
M: Dipeptidyl peptidase-4: a key player in chronic liver disease.
World J Gastroenterol. 19:2298–2306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Drucker DJ: The biology of incretin
hormones. Cell Metab. 3:153–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gier B, Butler PC, Lai CK, Kirakossian D,
DeNicola MM and Yeh MW: Glucagon like peptide-1 receptor expression
in the human thyroid gland. J Clin Endocrinol Metab. 97:121–131.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Broide E, Bloch O, Ben-Yehudah G, Cantrell
D, Shirin H and Rapoport MJ: GLP-1 receptor is expressed in human
stomach mucosa: analysis of its cellular association and
distribution within gastric glands. J Histochem Cytochem.
61:649–658. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gupta NA, Mells J, Dunham RM, et al:
Glucagon-like peptide-1 receptor is present on human hepatocytes
and has a direct role in decreasing hepatic steatosis in vitro by
modulating elements of the insulin signaling pathway. Hepatology.
51:1584–1592. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Svegliati-Baroni G, Saccomanno S,
Rychlicki C, et al: Glucagon-like peptide-1 receptor activation
stimulates hepatic lipid oxidation and restores hepatic signalling
alteration induced by a high-fat diet in nonalcoholic
steatohepatitis. Liver Int. 31:1285–1297. 2011. View Article : Google Scholar
|
|
17
|
Trevaskis JL, Griffin PS, Wittmer C, et
al: Glucagon-like peptide-1 receptor agonism improves metabolic,
biochemical, and histopathological indices of nonalcoholic
steatohepatitis in mice. Am J Physiol Gastrointest Liver Physiol.
302:G762–G772. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dhanesha N, Joharapurkar A, Shah G, et al:
Treatment with exendin-4 improves the antidiabetic efficacy and
reverses hepatic steatosis in glucokinase activator treated db/db
mice. Eur J Pharmacol. 714:188–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Panjwani N, Mulvihill EE, Longuet C, et
al: GLP-1 receptor activation indirectly reduces hepatic lipid
accumulation but does not attenuate development of atherosclerosis
in diabetic male ApoE(−/−) mice. Endocrinology. 154:127–139.
2013.PubMed/NCBI
|
|
20
|
Stumpf PK: Metabolism of fatty acids. Annu
Rev Biochem. 38:159–212. 1969. View Article : Google Scholar
|
|
21
|
Calder PC: N-3 polyunsaturated fatty acids
and inflammation: from molecular biology to the clinic. Lipids.
38:343–352. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patterson E, Wall R, Fitzgerald GF, Ross
RP and Stanton C: Health implications of high dietary omega-6
polyunsaturated Fatty acids (Review). J Nutr Metab.
2012:e5394262012. View Article : Google Scholar
|
|
23
|
Puri P, Baillie RA, Wiest MM, et al: A
lipidomic analysis of nonalcoholic fatty liver disease. Hepatology.
46:1081–1090. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Puri P, Wiest MM, Cheung O, et al: The
plasma lipidomic signature of nonalcoholic steatohepatitis.
Hepatology. 50:1827–1838. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poudel-Tandukar K, Sato M, Ejima Y, et al:
Relationship of serum fatty acid composition and desaturase
activity to C-reactive protein in Japanese men and women.
Atherosclerosis. 220:520–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chuang LT, Thurmond JM, Liu JW, Mukerji P,
Bray TM and Huang YS: Effect of conjugated linoleic acid on Delta-5
desaturase activity in yeast transformed with fungal Delta-5
desaturase gene. Mol Cell Biochem. 265:11–18. 2004. View Article : Google Scholar
|
|
27
|
Roke K, Ralston JC, Abdelmagid S, et al:
Variation in the FADS1/2 gene cluster alters plasma n-6 PUFA and is
weakly associated with hsCRP levels in healthy young adults.
Prostaglandins Leukot Essent Fatty Acids. 89:257–263. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maniongui C, Blond JP, Ulmann L, Durand G,
Poisson JP and Bézard J: Age-related changes in delta 6 and delta 5
desaturase activities in rat liver microsomes. Lipids. 28:291–297.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kröger J and Schulze MB: Recent insights
into the relation of Δ5 desaturase and Δ6 desaturase activity to
the development of type 2 diabetes. Curr Opin Lipidol. 23:4–10.
2012.
|
|
30
|
López-Vicario C, González-Périz A, Rius B,
et al: Molecular interplay between Δ5/Δ6 desaturases and long-chain
fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
Gut. 63:344–355. 2014.
|
|
31
|
Yamaguchi K, Yang L, McCall S, et al:
Inhibiting triglyceride synthesis improves hepatic steatosis but
exacerbates liver damage and fibrosis in obese mice with
nonalcoholic steatohepatitis. Hepatology. 45:1366–1374. 2007.
View Article : Google Scholar
|
|
32
|
Kawaguchi T, Sakisaka S, Sata M, Mori M
and Tanikawa K: Different lobular distributions of altered
hepatocyte tight junctions in rat models of intrahepatic and
extrahepatic cholestasis. Hepatology. 29:205–216. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kawaguchi T, Sakisaka S, Mitsuyama K, et
al: Cholestasis with altered structure and function of hepatocyte
tight junction and decreased expression of canalicular
multispecific organic anion transporter in a rat model of colitis.
Hepatology. 31:1285–1295. 2000. View Article : Google Scholar
|
|
34
|
Kawaguchi T, Yoshida T, Harada M, et al:
Hepatitis C virus down-regulates insulin receptor substrates 1 and
2 through up-regulation of suppressor of cytokine signaling 3. Am J
Pathol. 165:1499–1508. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kawaguchi T, Ide T, Taniguchi E, et al:
Clearance of HCV improves insulin resistance, beta-cell function,
and hepatic expression of insulin receptor substrate 1 and 2. Am J
Gastroenterol. 102:570–576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Krishna SM, Seto SW, Moxon JV, et al:
Fenofibrate increases high-density lipoprotein and sphingosine 1
phosphate concentrations limiting abdominal aortic aneurysm
progression in a mouse model. Am J Pathol. 181:706–718. 2012.
View Article : Google Scholar
|
|
37
|
Kleiner DE, Brunt EM, Van Natta M, et al:
Design and validation of a histological scoring system for
nonalcoholic fatty liver disease. Hepatology. 41:1313–1321. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Folch J, Lees M and Sloane Stanley GH: A
simple method for the isolation and purification of total lipides
from animal tissues. J Biol Chem. 226:497–509. 1957.PubMed/NCBI
|
|
39
|
Kenny PR, Brady DE, Torres DM, Ragozzino
L, Chalasani N and Harrison SA: Exenatide in the treatment of
diabetic patients with non-alcoholic steatohepatitis: a case
series. Am J Gastroenterol. 105:2707–2709. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ding X, Saxena NK, Lin S, Gupta NA and
Anania FA: Exendin-4, a glucagon-like protein-1 (GLP-1) receptor
agonist, reverses hepatic steatosis in ob/ob mice. Hepatology.
43:173–181. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gupta NA, Kolachala VL, Jiang R, et al:
The glucagon-like peptide-1 receptor agonist Exendin 4 has a
protective role in ischemic injury of lean and steatotic liver by
inhibiting cell death and stimulating lipolysis. Am J Pathol.
181:1693–1701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Leamy AK, Egnatchik RA and Young JD:
Molecular mechanisms and the role of saturated fatty acids in the
progression of non-alcoholic fatty liver disease. Prog Lipid Res.
52:165–174. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Matsumori R, Miyazaki T, Shimada K, et al:
High levels of very long-chain saturated fatty acid in erythrocytes
correlates with atherogenic lipoprotein profiles in subjects with
metabolic syndrome. Diabetes Res Clin Pract. 99:12–18. 2013.
View Article : Google Scholar
|
|
44
|
Kusunoki M, Tsutsumi K, Nakayama M, et al:
Relationship between serum concentrations of saturated fatty acids
and unsaturated fatty acids and the homeostasis model insulin
resistance index in Japanese patients with type 2 diabetes
mellitus. J Med Invest. 54:243–247. 2007. View Article : Google Scholar
|
|
45
|
Arrol S, Mackness MI and Durrington PN:
The effects of fatty acids on apolipoprotein B secretion by human
hepatoma cells (HEP G2). Atherosclerosis. 150:255–264. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kurek K, Piotrowska DM, Wiesiolek-Kurek P,
et al: Inhibition of ceramide de novo synthesis reduces liver lipid
accumulation in rats with nonalcoholic fatty liver disease. Liver
Int. Sep 25–2013.(Epub ahead of print).
|
|
47
|
Araya J, Rodrigo R, Videla LA, et al:
Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in
relation to hepatic steatosis in patients with non-alcoholic fatty
liver disease. Clin Sci (Lond). 106:635–643. 2004. View Article : Google Scholar
|
|
48
|
de Gomez Dumm IN, de Alaniz MJ and Brenner
RR: Effect of dietary fatty acids on delta 5 desaturase activity
and biosynthesis of arachidonic acid in rat liver microsomes.
Lipids. 18:781–788. 1983.PubMed/NCBI
|
